Diagnostic Utility and Prognostic Significance of Circulating Tumor Cell Assay CNSide in Patients With Suspicion for Leptomeningeal Metastases - Part 2
In part two of this series, Dr. Justin Abbatemarco and Dr. Shreya Louis discuss how this technology was developed and how it has evolved. Read more about this abstract on the AAN website .
Read the full articleYou might also wanna read
ctDNA-Guided Intraventricular Therapy for CNS Malignancies
Conditions : Leptomeningeal Disease; Glioblastoma; Brain Metastases; Non-Small Cell Lung Cancer; Breast Cancer Interventions : Device: CSF c
MRD Assessment May Refine Prognosis After CAR-T for Follicular Lymphoma
(MedPage Today) -- A study presented at the American Society of Clinical Oncology (ASCO) annual meeting suggested that circulating tumor (ct
Dual tumour–myeloid targeting of glioblastoma with GPNMB CAR-T cells
Nature, Published online: 01 July 2026; doi:10.1038/s41586-026-10641-1 Integrated multi-omic profiling of glioblastoma reveals GPNMB as a sh
Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
Conditions : Diffuse Intrinsic Pontine Glioma; DIPG; Brain Tumor; CNS Tumor; Central Nervous System Tumor; Pediatric Cancer; Adult Cancer Pa
AI-guided discovery identifies GPNMB as promising CAR T cell target for multiple cancers
An AI-guided framework integrating high-resolution cellular atlases, public knowledge databases, and large language models enables a modular
New Lab Advances Detect Cancer and Brain Injury Earlier—What It Means for You
Advanced lab tests using monoclonal antibodies are helping doctors detect cancer and brain injury earlier than ever before. Understanding ho
Comments
Sign in to join the conversation.
No comments yet. Be the first.